Sotac Pharmaceuticals

Sotac Pharmaceuticals EBIT per Share

The EBIT per Share of Sotac Pharmaceuticals (SOTAC.NS) as of Oct 20, 2026 is 8.88 INR. In the previous year, EBIT per Share was 4.69 INR — a change of 89.42% (higher).

EBIT per Share

8.88INR

YoY

89.42%

Last updated:

EBIT per Share of Sotac Pharmaceuticals is 2025 8.88 INR. EBIT per Share of Sotac Pharmaceuticals was 2024 4.69 INR. It decreases by 89.42% higher compared to the previous year.

The Sotac Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
0.42 INR
Jan 1, 2021
-1.03 INR
Jan 1, 2022
6.19 INR
Jan 1, 2023
5.96 INR
Jan 1, 2024
4.69 INR
Jan 1, 2025
8.88 INR
The Sotac Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
8.88INR+89.42%
4.69INR-21.29%
5.96INR-3.82%
6.19INR-701.03%
-1.03INR-346.65%
0.42INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals Ltd., headquartered in Ahmedabad, Gujarat, operates in the Health Care sector, specializing in pharmaceutical manufacturing. The company develops and manufactures products such as Non Beta-Lactam tablets, capsules, syrups, and external preparations on a contract basis for various marketers. Its therapeutic portfolio covers Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Anti-Cold, Anti-Allergic, Derma Products, and a wide range of antibiotics including Non-IP-Lactams and Cephalosporin. Listed on 13 April 2023, Sotac employs 89 people and has subsidiaries including SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience. Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sotac Pharmaceuticals stock

EBIT per Share of Sotac Pharmaceuticals is 8.88 INR in 2025.

EBIT per Share of Sotac Pharmaceuticals changed from 4.69 INR to 8.88 INR, representing a 89.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sotac Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sotac Pharmaceuticals